GLIS2 and acute myeloid leukemia: Using this approach (Fig. 1A), more than 1 000 cancer cell lines have been screened in the context of the Cancer Dependency Map (17, 27) (https://depmap.org/portal), including two CBFA2T3::GLIS2 fusion AML cell lines (CMS and M-07e) and 26 CBFA2T3::GLIS2 non fusion AML cell lines (12).